Name: Advancing Pharmacovigilance by Pharmaceutical Commerce Magazine
Duration: 19 min 57 s
Description: Glenn Carroll, safety leader and principal at Deloitte Consulting, a firm that has collaborated with a Big Pharma company on an AI software-as-a-service platform, details the obstacles that drug safety providers face today, and how the competitive landscape is evolving as new entrants join the field.

Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s boarders.

Episode 89: Cellicon Valley Outlook

Glenn Carroll, safety leader and principal at Deloitte Consulting, a firm that has collaborated with a Big Pharma company on an AI software-as-a-service platform, details the obstacles that drug safety providers face today, and how the competitive landscape is evolving as new entrants join the field.

Advancing Pharmacovigilance

Pharmaceutical Commerce Magazine

Related tracks